India’s new draft national policy for rare disease and the road to accessing gene therapies

By Ciaran Cassidy, Snr Analyst Email: ccassidy@partners4access.com With one of the fastest-growing economies and the second largest population in the world India is a market of increasing interest to the biopharmaceutical industry.1,2 However, the potential for access to innovative rare disease therapies, such as gene therapies, is not particularly well supported by the central government…